Artboard 1Icon/UI/CalendarIcons/Ionic/Social/social-pinterest

Inside track: Healthcare

26 July 2021

#Dispute Resolution & Litigation

Inside track: Healthcare

In the media

AMA says AstraZeneca vaccine critical to combat growing Covid-19 Delta outbreak
AMA President Dr Omar Khorshid has called on the Australian Technical Advisory Group on Immunisation to review its advice on the AstraZeneca vaccine in response to the growing risks posed by the outbreak of the Delta variant in NSW (23 July 2021).  More...

More community pharmacies and additional GPs to deliver COVID-19 vaccines
Thousands of community pharmacies and additional GPs across Australia will be invited to join the COVID-19 vaccine rollout.
This additional workforce will be brought on board to support pharmacies and GPs already delivering COVID-19 vaccines in cities, regional, rural and remote areas (22 July 2021).  More...

Baby sleep products raise eyes at safety
The Australian Competition and Consumer Commission (ACCC) has reviewed the safety of inclined infant sleeping products and is now seeking feedback on its findings. The ACCC’s Issues Paper, including information on how to make a contribution, can be accessed at this here (22 July 2021).

Clinical trial national approach will benefit patients and our economy
Medicines Australia welcomes the clinical trial ‘one-stop-shop’ consultation, recently announced by the Australian Commission on Safety and Quality in Health Care. Clinical trials in Australia are a significant enabler for faster access for patients and make an important contribution to the economy but we require a consistent, national approach to remain competitive (20 July 2021).  More...

Queensland

Trucking health services to remote Queensland
Heart of Australia's HEART 4 truck hits the road to bring life-saving services to remote and rural Queensland (21 July 2021).  More...

Development of blood vessel repair therapy accelerated
UniQuest — The University of Queensland’s technology transfer company — has partnered with global biotechnology company CSL to accelerate the development of a potential treatment for the repair of blood vessels damaged by inflammation (19 July 2021).  More...

Disclaimer
The information in this publication is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavour to provide accurate and timely information, we do not guarantee that the information in this publication is accurate at the date it is received or that it will continue to be accurate in the future. We are not responsible for the information of any source to which a link is provided or reference is made and exclude all liability in connection with use of these sources.

Share this